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EARLY RISK OF RECURRENT STROKE AFTER TRANSIENT
ISCHEMIC ATTACK/MINOR STROKE
The most commonly quoted risk of 1e2% at 1 week and 4%
at 1 month are considered to be underestimated because
patients are generally seen several weeks after a transient
ischemic attack (TIA) or minor stroke.1,2 In a study of pa-
tients presenting to the emergency department within 24 h
of a TIA, Johnston et al. reported a risk of stroke of around
5% at 2 days.3 Coull et al. reported on early risk of stroke
after TIA/minor stroke, and found that the risk of recurrent
stroke was 8.0% at 1 week, 11.5% at 1 month, and 17.3% at
3 months, and after a minor stroke they were 11.5%, 15.0%,
and 18.5%, respectively.4 This is critical, as the beneﬁt from
carotid intervention (carotid endarterectomy or stenting)
falls rapidly with time after a TIA/minor stroke.4 Several
other authorities have reported that the risk of recurrent
stroke after TIA/minor stroke is highest within the ﬁrst 7e
14 days in patients with carotid disease.5e8
Two recent meta-analyses showed that the risk of stroke
after TIA was 6.7% at 48 h and 10.0% at 1 week.7,8 Patients
with carotid artery stenosis showed the highest rate of
stroke after TIA (4.0% at 1 week, 12.6% at 30 days, and
19.2% at 3 months).9 Almost half of all strokes observed
within 1 week occur within the ﬁrst 24 h.10 Rothwell and
Warlow reported on a pooled cohort of 549 patients whose
stroke was preceded by a TIA;11 43% of the index TIAs were
observed within 1 week of the stroke, while 17% occurred
on the same day as the stroke.
Pooled data from the North American Symptomatic Ca-
rotid Endarterectomy Trial (NASCET) and the European Ca-
rotid Surgery Trial (ECST) showed that the beneﬁt from
carotid endarterectomy (CEA) depends on the time of CEA
after the index event and the degree of stenosis.12 Mono
et al. reported on the risk of early recurrent cerebrovascular
events in symptomatic carotid stenosis.13 Eighty-ﬁve pa-
tients underwent CEA and nine patients had carotid artery
stenting (CAS). The median time from the onset of symp-
toms to carotid intervention was 5 days. Twenty-one (22%)
patients underwent carotid intervention within 48 h of
being admitted. There were 15 (13%) recurrent cerebro-
vascular events in 12 patients in the period between
admission and carotid intervention: ﬁve TIAs (5.3%), one
amaurosis fugax (1.1%), and three strokes (3.2%) observed
within the ﬁrst 72 h (a total of 9.6%) of admissions. One TIA
(1.1%) occurred between 72 h and 1 week, and ﬁve TIAs
(5.3%) were noted after 1 week. The actuarial cerebrovas-
cular recurrence rates were 11.4% within 72 h of admission,
2.4% between 72 h and 1 week, and 7.9% after 1 week. The
rate of procedure-related cerebrovascular events was 4.3%.
Carotid intervention performed within the ﬁrst 48 h and
those performed after 48 h had similar outcomes.
Validation and reﬁnement of scores to predict very early
stroke risks after TIA was reported by Johnston et al.14 The
ABCD (age, blood pressure, clinical features, duration of TIA,
and diabetes) and California scoring systems were exten-
sively analyzed and validated cohorts consisting of 4,799
patients with TIAs, and renamed the ABCD2 score
(Table 1).14 As noted in Table 1, patients with a score of 3
have a very low stroke risk of 1.0% at 2 days, 1.2% at 1
week, and 3.1% at 3 months. Patients with a score of 4
were associated with an increased early stroke risk, with the
greatest risk being noticed in patients with a score of 6e7,
where the risk of stroke was 8.1% at 2 days, 11.7% at 1
week, and 17.8% at 3 months. Accordingly, the UK National
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Stroke Strategy recommends that patients with an ABCD2
score of 3 can be assessed within 1 week of symptom
onset, while patients with a score of 4 should be evalu-
ated in <24 h. Patients with an ABCD2 score of 4 and an
ipsilateral carotid stenosis of 50e99% should be admitted
to the hospital and carotid intervention (CEA) should be
performed within 48 h, unless contraindicated.15
Table 2 summarizes the risk of early recurrent strokes in
patients with symptomatic  50% carotid artery stenosis in
commonly quoted studies.6,9,13,16,17
TIMING OF CAROTID INTERVENTION
The timing of carotid intervention in symptomatic patients
after the onset of TIA or minor stroke is highly controver-
sial.18e29 If carotid intervention is performed urgently or
within the ﬁrst few days of onset of symptoms, the risk of
procedural stroke has to be weighed against the risk of early
stroke recurrence. It is generally believed that carotid
intervention (CEA) for a stroke in progress carries a high
operative risk; however, as soon as the patient with stroke
or TIA becomes stable, very early carotid intervention may
be beneﬁcial.24e26 On the contrary, data from the Swedish
Vascular Registry on 2,596 CEAs for symptomatic carotid
stenosis showed that patients treated within 2 days after
the neurological event had a signiﬁcantly higher perioper-
ative risk compared with patients treated after 3e7 days,
8e14 days, or 15e180 days: 11.5% versus 3.6%, 4.0%, and
5.4%, respectively (p < .001).23 A multivariate analysis
showed that timing was an independent risk factor for
perioperative stroke and death (patients treated at 0e2
days had a relative odds ratio of 4.24; p < .001) compared
with patients treated within 3e7 days. Table 3 summarizes
procedural adverse events in patients according to time of
intervention. Similarly, Rockman et al. conducted a review
of 2,537 CEAs (1,158 symptomatic).21 CEA was considered
“early” if performed in 4 weeks of symptoms and
“delayed” if performed beyond that period. Patients who
underwent early CEA (for TIA or stroke) were signiﬁcantly
more likely to experience a perioperative stroke than pa-
tients who underwent delayed CEA: 5.1% versus 1.6%
(p ¼ .002). Both authorities felt that this higher perioper-
ative risk of stroke can be attributed, in part, to reperfusion
brain zones with loss of autoregulation, hyperperfusion, or
hemorrhagic conversion of acute infarct.
It is generally believed that patients beneﬁt most from
carotid intervention (CEA) if it is done within 14 days after
the onset of symptoms.12 Accordingly, the current guidelines
Table 1. Prediction of early stroke risk after suffering a transient ischemic attack (TIA): the ABCD2 scoring system (taken from Naylor15).a
Score
A Age 60 1
B Blood pressure Systolic 140 mmHg or diastolic 90 mmHg 1
C Clinical features Unilateral weakness
Speech impairment (no weakness)
2
Speech impairment (no weakness) 1
D Duration of TIA 60 min 2
10e59 min 1
D Diabetes Diabetes
Max score 7
ABCD2 score Risk of stroke (%)
n 2 d 7 d 90 d
0e3 1628 1.0 1.2 3.1
4e5 2169 4.1 5.9 9.8
6e7 1,012 8.1 11.7 17.8
Note. aData derived from Johnston et al.14
Table 2. Early stroke recurrence in patients with symptomatic 50% carotid artery stenosis in ﬁve series.
Event Lovett et al.9
(n ¼ 245)
Fairhead et al.6
(n ¼ 85)
Ois et al.16
(n ¼ 163)
Johanson et al.17
(n ¼ 230)
Mono et al.13
(n ¼ 94)
Year reported 2004 2005 2009 2013 2013
TIA NA NA 26 30 34
AF NA NA 0 23 6
Stroke 100 NA 74 42 60
Very early recurrent
stroke/stroke in progress (48e72 h)
NA NA 17 5 3
Stroke recurrence rate at 48 and 72 h NA NA 17 5 4
Recurrent stroke within 1 week 5 NA 22 8 3
Stroke recurrence rate @ 1 wk. 5 NA 22 NA 4
Recurrent strokes within 2 weeks
of symptom onset
NA 17 23 11 3
Stroke recurrence rate at 2 weeks NA 24 23 NA 4
Note. Values are given as %. TIA ¼ transient ischemic attack; NA ¼ not applicable; AF ¼ atrial ﬁbrillation.
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of the American Heart Association and the European
Vascular Surgery Society recommend that CEA should be
performed within 14 days after the index event.18,19 The
guidelines from the United Kingdom National Stroke Strat-
egy also suggest that intervention should be performed
within 48 h of TIA or minor stroke.15 It should be noted that
this recommendation applies to patients who present with
TIAs, amaurosis fugax, or nondisabling stroke. Unfortunately,
none of the randomized carotid trials comparing CAS with
CEA in symptomatic patients have stratiﬁed their outcome to
adjust for delay of intervention from onset of symptoms.
A similar observation was noted in patients who under-
went CAS. Gray et al. reported, on behalf of the CAPTURE
registry, that patients presenting with a TIA/minor stroke
who underwent CAS within 14 days of symptom onset had a
higher risk of periprocedural stroke (odds ratio 2.52).27
Topakian et al. also noted similar ﬁndings where early CAS
within 2 weeks of symptoms suffered higher 30-day stroke/
death rates than patients who had later CAS (26.0% vs.
1.9%).28 In contrast, Groschel et al. reported on their
experience in 320 patients and observed no difference in
the 30-day stroke/death rates between patients who had
CAS before 14 days versus after 14 days (7.0% vs. 9.6%).29
Meanwhile, Naylor reported that performing CEA or CAS
within 14 days with a 10% risk would prevent around 150
strokes at 5 years per 1,000 CEAs;15 however, with CEA/CAS
delayed until >4 weeks, with a 3% risk, 100 strokes would
be prevented.
CAS IN RECENTLY SYMPTOMATIC PATIENTS CAN BE DONE
SAFELY WITH RESULTS NOT INFERIOR TO CEA
As indicated earlier, few commonly quoted studies have
reported increased procedural risk after urgent CEA, which
raised the question as to whether or not early CAS in these
circumstances would be safer than, or at least not inferior
to, CEA. CAS has been shown to be noninferior to CEA in
selective patients when combined end points of stroke,
myocardial infarction (MI), and death were used.18,19
Several studies have analyzed the optimal timing of
performing CAS in patients with symptomatic carotid artery
stenosis.28e41 Groschel et al. analyzed a group of 320 pa-
tients with a median delay before CAS of 19 days.29 The
minor stroke, major stroke, death, and all strokes/deaths
rates for procedures done <14 days after the event were
3.5%, 1.4%, 2.1%, and 7.0%, respectively, in contrast to
those at  14 days, which were 7.3%, 2.3%, 0%, and 9.6%,
respectively. The time delay was not signiﬁcantly associated
with periprocedural complications, and they felt that CAS
should be performed as soon as possible to maximize the
beneﬁt of intervention in reducing the risk of stroke. Simi-
larly, Lin et al. analyzed a prospective CAS registry of 224
symptomatic patients where, based on time to CAS from
symptom onset, patients were classiﬁed into early (4
weeks) and late (>4 weeks) treatment groups.37 The me-
dian time for early CAS was 8 days, and it was 90 days for
late CAS. The periprocedural stroke rate in the early CAS
group was 3.5% versus 6% in the late CAS group (p ¼ .50).
The 30-day stroke, MI, or death rates were also similar. They
concluded that CAS can be performed safely immediately
following nondisabling strokes.37
Setacci et al. analyzed 43 patients with symptomatic
>70% carotid stenosis who had urgent CAS (within 24 h) or
deferred CAS (within 30 days), with a mean time of 6.5
days.38 The new adverse events in the patients with TIA at 1
month were one death (3.8%, not stroke related) and one
TIA (3.8%). In the minor stroke group at 1 month, 10/17
(59%) patients experienced improvement in their initial
neurological event, while in 6/17 (35%) of patients, the
deﬁcit remained stable; only one patient had neurological
impairment. The authors felt that early treatment with CAS
is both feasible and safe in selected patients with a ﬁrst
episode or recurrent TIA/minor stroke.38
Recently, Wach et al. reported the results of 221 CAS
procedures,39 and their ﬁndings are summarized in Table 4.
The primary outcome was not different among groups
stratiﬁed based on CAS timing. They concluded that early
CAS (within 2 days) carries no additional risk compared with
CAS after 2 days or any other timing. They also felt that
early CAS may represent a reasonable noninferior option for
acute carotid revascularization to minimize the risk of
perioperative stroke and overall perioperative
complications.39
Table 3. Procedural adverse events in patients subdivided according to time to intervention (taken from Table 2 in Stromberg et al.23).
0e2 d 3e7 d 8e14 d 15e180 d Total pa
Minor stroke 10 (6.8) 10 (1.2) 13 (1.9) 23 (2.4) 56 (2.2) <.001
Major strokeb 6 (4.1) 10 (1.2) 10 (1.5) 16 (1.7) 42 (1.6) .097
Mortality 3 (2.0) 10 (1.2) 7 (1.0) 16 (1.7) 36 (1.4) .640
Mortality and any stroke 17 (11.5) 29 (3.6) 27 (4.0) 52 (5.4) 125 (4.8) <.001
Note. Values are given as n (%).
a
Pearson’s chi-square test.
b
Major stroke includes major stroke-related death.
Table 4. Comparison of perioperative complication rates within
and after 2 and 8 days.
2 d >2 d p <8 d 8 d p
Patients (n) 70 151 158 63
Ischemic stroke 1.4 2 1.000 2.5 0 1.000
MI 0% .7 1.000 0 1.6 .285
Death 4.3 0 .031 1.9 0 .560
Stroke/MI/death 7.1 4.0 .331 5.7 3.2 .733
Hemorrhage 2.9 1.3 .593 1.9 1.6 1.000
Note. Values are given as % unless otherwise stated.
MI ¼ myocardial infarction.
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Table 5. Summary of several series of urgent carotid artery stenting (CAS) performed for patients with acute transient ischemic attack (TIA)/stroke.
Reference CAS (n) Indication Carotid stenosis (%) Event-to-CAS
Time interval
30-day Stroke/death
Al-Mubarak et al., 199930 44 Acute stroke (n ¼ 2)
Crescendo TIAs (n ¼ 31)
Stable stroke (n ¼ 11)
>70 Mean 3 d (range 2e6) 4.5%
(one major and
one minor stroke)
Anzuini et al., 200141 13 Post-CEA neurological eventa >70
(dissection and thrombosis)
Mean 46 min 11/13 complete remission of neurologic events
Zaidat et al., 200431 38 Acute stroke
Median NIHSS ¼ 8
>70%
28 patients
ICA occlusions (n ¼ 4)
Dissections (n ¼ 6)
Mean 2.3  1.6 d 7.7%
(two minor strokes and one death secondary
to ICH
Imai et al., 200532 17 Acute stroke
Fluctuating stroke
Stroke in evolution
Median NIHSS ¼ 12
>70%
ICA occlusions (n ¼ 4)
Mean 2.3  2.4 d 12% (distal embolism [stroke]
and one ICH)
Jovin et al., 200533 25 Acute stroke
(n ¼ 15; mean NIHSS ¼ 16  5)
Subacute ﬂuctuating stroke
(n ¼ 10; mean NIHSS ¼ 12  5)
All ICA occlusion Mean 5.0  .9 h
Mean 30  35 h
12% (two strokes and death, and one
asymptomatic ICH)
Nikas et al., 200734 18 Acute stroke (NIHSS > 4) >70 Mean 2.35  1.30 h 22% (one major stroke, one minor stroke,
one asymptomatic ICH, one death)
Topakian et al., 200728 23 TIA
Moderate stroke
All cases > 60 <14 days 26% (three major strokes, three minor strokes)
Wang et al., 200735 5 Acute stroke
(mean NIHSS ¼ 13.8, range 7e22)
>70 Mean 4.4 h
(range 3.6e5.0 h)
20% (one ICA in-stent thrombosis and death)
Miyamoto et al., 200836 10 Acute stroke (50%)
Stroke in evolution (50%)
>70
Near occlusions (n ¼ 5)
Mean 7.2 h (range 3e24) 20% (two strokes [one death])
Groschel et al., 200829 142 Stroke (43%)
TIA (58%)
All cases > 70
ICA occlusions (n ¼ 5)
Mean 8.3  3.3 d 7% (two major strokes, ﬁve minor strokes,
three deaths)
Lin et al., 201037 224
(early ¼ 122;
late 102)
Acute stroke
TIA
>70 Early CAS: mean 8 d
Late CAS:
mean 90 d
Early CAS: 6.0% (3.5% stroke)
Late CAS: 8.3% (6.0% stroke)
Setacci et al., 201038 43 TIA (n ¼ 26)
Minor stroke (n ¼ 17)
>70 Mean TIA: 24 h
Mean stroke: 6.5 d
For TIA: one TIA,
one death
For stroke: 59% improved, 35% stable
Wach M et al., 201439 221 TIA/minor stroke >70 2 d (CAS, n ¼ 70)
<8 d (CAS, n ¼ 158)
8 d (CAS, n ¼ 63)
2 d: 7.1%
<8 d: 4.5%
8 d: 2.8%
Macdonald, in press40 91 TIA/minor stroke >70 (n ¼ 84)
>50 to < 79 (n ¼ 7)
<14 days 3.4% (stroke/MI/death)
Note. CEA ¼ carotid endarterectomy; NIHSS ¼ National Institutes of health Stroke Scale; ICA ¼ internal carotid artery; ICH ¼ intracerebral hemorrhage.
a
This was done as emergency stenting to treat neurologic complications occurring after CEA.
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Macdonald also analyzed the results of CAS in 91 patients
treated within 2 weeks of the index event in three experi-
enced UK units: Newcastle, Shefﬁeld, and Atkinson Morley/
St George’s.40 This was a retrospective review of prospec-
tively collected data for acute symptoms of amaurosis fugax
(17 patients; 19%), TIA (30 patients; 33%), and minor stroke
(44 patients; 48%). The 30-day perioperative rate for all
stroke/MI/death was 3.4%, with an all stroke/death rate of
2.3%, an all stroke rate of 2.3%, and a death rate of 0%. They
concluded that CAS, performed within 2 weeks of the index
event, is feasible and may be safe. They also emphasized
that these results are from experienced CAS units and may
not be extrapolated to less experienced units.40
CAS can also be used in emergency situations to treat
neurological complications occurring after CEA. Anzuini
et al. reported on their experience of 18 of 995 (1.8%)
patients with CEA patients that experienced perioperative
neurological events.41 Of these, 13 patients underwent
emergency carotid angiogram/CAS within 20 min. Complete
resolution of the neurological events occurred in 11 of the
13 patients treated by CAS and in one of the ﬁve patients
treated by surgical re-exploration (p ¼ .024). The authors
felt that CAS seemed to be a safe and effective therapy in
treatment of perioperative stroke complicating CEA, espe-
cially when carotid dissection represents the main
etiology.41
Table 5 summarizes the results of 14 series of urgent CAS
for patients with acute TIA/minor strokes.
SELECTION CRITERIA/CAUTION FOR URGENT CAS IN
RECENTLY SYMPTOMATIC PATIENTS
Selection for urgent CAS should be individualized. In addi-
tion to TIAs, some authorities recommended urgent CAS for
patients with a small infarction volume of 10e12 cm3 or
less, mild-to-moderate neurological deﬁcits (with a grade of
<8 on the National Institute of Health Stroke Scale), and
thrombolysis within 6 h of onset of symptom for hyperacute
CAS.31
Overall, urgent CAS should be avoided in patients who
show evidence of ischemic infarct of >2.5 cm in diameter,
patients with intracranial hemorrhage, recent carotid oc-
clusion lasting > 6 h, a Rankin score > 3, and a ﬂuctuating
level of consciousness (unstable patients). Another concern
regarding urgent CAS is the fact that, after stenting, the
plaque is only remodeled and its stabilization is essential to
avoid further embolic events during the immediate post-
operative period. The type of stent has been debated,
particularly the important role of scaffolding of the plaque
by the struts of the stents and whether an open versus
closed cell ought to be used in these situations.42
CEREBRAL PROTECTION DEVICES DURING URGENT CAS
The use of cerebral protection devices during urgent CAS is
controversial.33,34 Nikas et al. recommend the use of an
embolic protection device during CAS, when feasible;34
however, Jovin et al. felt that the beneﬁt of CAS seems to
be greatest when performed in the fastest possible time,33
and the introduction of a ﬁlter device would delay this
timing. They also felt that traversing the occlusion required
wires that were more steerable than the ﬁlter wires
currently used, while the presence of proximal occlusion
precludes visualization of the arterial segment where the
ﬁlter should be deployed. Jovin et al. also reported that
once the lesion is crossed with a wire, angiography, using a
microcatheter, will aid in documenting the length of the
stenosis/occlusion and assessing the presence of an intra-
luminal thrombus.33
Other authorities recommend the use of proximal
occlusive devices (with ﬂow reversal) to minimize cerebral
embolization from vulnerable plaque during manipula-
tion.43 A recent randomized trial of patients receiving CAS
revealed that proximal protection, compared with distal
ﬁlter protection, reduced the embolic load as manifested by
fewer high-intensity signals on transcranial Doppler and
fewer new lesions on diffusion weighted magnetic reso-
nance imaging.44
CONCLUSIONS
The optimal timing of intervention, CEA or CAS, needs to be
addressed with much more solid data, preferably from a
randomized trial. In the reported studies, it seems that early
CAS, within a few days of the qualifying index event, may
offer a non-inferior treatment compared with delayed CAS.
In contrast to CEA, which has been reported to incur a
greater incidence of perioperative complications in the
early setting after symptoms occur, particularly if it is done
within the ﬁrst 48 h. Therefore, early CAS may represent an
option, not inferior to CEA, in minimizing the risk of
recurrent early stroke and the overall risk of perioperative
complications. However, because of the sample size, further
studies with larger sample sizes are warranted.
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EDITORS’ COMMENT
Trans-Atlantic Debate: Whether Carotid Endarterectomy is Safer than
Stenting in the Hyperacute Period After Onset of Symptoms
T.L. Forbes, Associate Editor, Journal of Vascular Surgery
Division of Vascular Surgery, University of Toronto, 200 Elizabeth St, Eaton North 6-222, Toronto, ON M5G2C4, Canada
It’s important to remember constantly that the purpose of
carotid interventions, whether it’s an endarterectomy (CEA)
or stent (CAS), is to prevent future ipsilateral hemispheric
neurological events. Our debaters appear to be in agree-
ment on several issues, namely that although early in-
terventions following neurological eventsmay pose a higher
risk of complications, they prevent more events than
delayed procedures. As Professor Naylor points out, a
recently symptomatic carotid stenosis is often thrombus
lined and may result in a higher risk of further symptoms in
the short term, and when manipulated by surgical inter-
vention or stenting, compared with a more mature lesion.
Until now, CEA has been proposed as the optimal early
intervention following symptoms to prevent further events;
however, is there new information that might offer CAS as
an alternative?
Our debaters review the literature and their own expe-
rience in exploring this. In general, both agree that there is
currently insufﬁcient evidence to support CAS as an equiv-
alent therapy in the hyperacute period following symptoms.
Except for the occasional exception, such as the report from
the SwedVasc Registry,1 procedural risks following CEA in
the early postsymptom period are quite low and accept-
able. However, procedural risks following CAS in the early
postsymptom period are much higher, except for the rare
exception.2 So it appears that surgical manipulation (CEA) of
a recently symptomatic carotid stenosis, with its thrombus
lining and intraplaque haemorrhage, continues to have less
procedural risk than the manipulations required with CAS.
Future technological advances may change this, but CEA is
the preferred therapy at this point.
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